Eos Portfolio

Meet our inspiring founders. Companies are defined by people and their performance.

Eos first invested: April, 2023
Led by: Rowan Armstrong
Bioliberty creates soft robotics technology to provide social care services to improve patient outcomes.
Eos first invested: October, 2024
Led by: Simon Aspland
Eos first invested: September, 2025
Led by: Arpan Desai
Eos first invested: April, 2022
Led by: Led by: Lorna Ewart
Carcinotech is a MedTech company manufacturing 3D printed mini tumours developed from patient-specific cancer stem cells, primary cells and established cell lines.
Eos first invested: August, 2023
Led by: Lee Cronin
Chemify is building the digital chemistry infrastructure to enable worldwide access to any desired compound instantly and on-demand
Eos first invested: November, 2024
Led by: Jessica Birt
Eos first invested: June, 2020
Led by: Clare Waring
Europes first cancer drug accelerator. Finding assets, creating spin-outs, commercialising cancer therapies.
Eos first invested: February, 2019
Led by: Prof. Matthew J Baker
Offers a revolutionary spectroscopic liquid biopsy with artificial intelligence for the early detection of cancer and other diseases.
Eos first invested: August, 2025
Led by: Asel Sartbaeva
Eos first invested: January, 2020
Led by: Gavin Munro
Formed in 2014 to offer Adjusta-Cone® as the world’s first fully adjustable differential pressure cone meter for natural gas.
Eos first invested: June, 2012
Led by: Owain Millington
Eos first invested: June, 2023
Led by: David Venables
Laverock Therapeutics is developing a unique gene silencing platform for the creation of programmable advanced therapies.
Eos first invested: April, 2024
Led by: Nico Fenu
Eos first invested: June, 2022
Led by: Giovanna Laudisio
Biodegradable, sustainable and cost competitive cellulose microparticles to replace plastic microbeads
Eos first invested: February, 2024
Led by: Paul Cable
Eos first invested: April, 2018
Led by: Gary Beale
An award winning Scottish sensors company utilising thin-film processes to eliminate conventional limitations in ultrasound sensors.
Eos first invested: February, 2020
Novel Technologies has developed a technology where pure silver particles are incorporated into fibres as a antimicrobial coating for paints and textiles in a way that is ecologically sound and non-toxic to humans.
Eos first invested: September, 2022
Led by: Richard Hammond
Penrhos Bio offers Remora technology, inspired by nature, that protects against bacteria, fungi, and algae, to provide self-cleaning surfaces.
Eos first invested: July, 2021
Led by: Richard Kuo
Specializes in maximizing RNA and DNA sequencing efficiency for the discovery and detection of nucleic acid biomarkers.

Latest news

Chemify Receives an Additional Grant to Accelerate Digital Chemistry Small-Molecule Discovery for Tuberculosis
11 December 2025
Strathclyde Spinout Dxcover wins Deal of the Year (sub £10 Million) at the Insider Scotland Dealmakers Awards 2025
20 November 2025

This website uses cookies to ensure you get the best experience on our website. By continuing to browse on this website, you accept the use of cookies for the above purposes.